Add BrightSurf on Google Email

University of California - San Francisco


New strategy to cut heart attack risk is effective in initial test

A new drug has been found safe and effective at reducing levels of 'bad' LDL cholesterol by up to 40 percent, a promising approach for treating high cholesterol and related conditions. The drug accelerates the natural process of ridding the body of LDL, offering an alternative to statins and potentially complementing their use.

SourceUniversity of California - San Francisco·JournalProceedings of the National Academy of Sciences·DateDec 17, 2007

On-screen smoking in movies linked to young adult smoking behavior

A new study by the University of California, San Francisco, found that exposure to on-screen smoking in movies is strongly correlated with beginning or becoming established smokers among young adults aged 18-25. The research team also identified positive expectations about smoking and exposure to friends and relatives who smoke as key ...

SourceUniversity of California - San Francisco·JournalAmerican Journal of Preventive Medicine·DateOct 2, 2007

Translating form into function

A team of scientists, led by UCSF's Brian Shoichet, successfully translated the structure of an enzyme into its function. By modifying a molecular docking technique, they predicted the natural molecule that triggers enzyme action, confirming the approach's potential to determine how key enzymes work in the body.

Class of PCB's causes developmental abnormalities in rat pups

Researchers found that a specific class of PCB causes significant developmental abnormalities in rat pups whose mothers were exposed to the toxicant during pregnancy and early nursing. The study suggests that non-coplanar PCBs may be particularly hazardous due to their stability and prevalence in environmental samples.

SourceUniversity of California - San Francisco·JournalProceedings of the National Academy of Sciences·DateApr 23, 2007